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Supplemental Table S1. 
 
 
P. falciparum gene 
identifier 
P. berghei gene 
identifier 
Protein 
superfamily 
PlasmoDB name (if given) Conserved domain (s) Reference (s) 
PF3D7_0629700 
 
PBANKA_1128500 SET SET domain protein, putative (SET1) i) SET-domain 
ii) PHD-domain 
iii) Bromodomain 
iv) HDAC interaction domain 
(Cui et al., 2008; Volz 
et al., 2010; Duffy et 
al., 2013) 
PF3D7_1322100 
 
---- SET Histone-lysine N-methyltransferase 
SET2 (SET2/PfSETvs) $ 
i) SET-domain 
ii) PHD-domain 
 
(Cui et al., 2008; 
Jiang et al., 2013) 
PF3D7_0827800 
 
PBANKA_0702900 SET SET domain protein, putative (SET3) i) SET-domain 
ii) Pre-SET domain 
(Cui et al., 2008; 
Jiang et al., 2013) 
PF3D7_0910000 
 
PBANKA_0811200 SET SET domain protein, putative (SET4) i) SET-domain 
 
(Cui et al., 2008; Volz 
et al., 2010; Jiang et 
al., 2013) 
PF3D7_1214200 
 
PBANKA_1430000 SET Histone-lysine N-methyltransferase 
(SET5) 
i) SET-domain 
 
(Cui et al., 2008; Volz 
et al., 2010; Jiang et 
al., 2013) 
PF3D7_1355300 
 
PBANKA_1131800 SET Histone-lysine N-methyltransferase 
(SET6) 
i) SET-domain 
 
(Cui et al., 2008; Volz 
et al., 2010; Jiang et 
al., 2013) 
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PF3D7_1115200 
 
PBANKA_0932500 SET Histone-lysine N-methyltransferase 
SET7 (SET7) $ 
i) SET-domain 
 
(Cui et al., 2008; 
Jiang et al., 2013; 
Chen et al., 2016) 
PF3D7_0403900 
 
PBANKA_1001600 SET SET domain protein, putative (SET8) i) SET-domain 
ii) PHD-domain 
(Cui et al., 2008; Volz 
et al., 2010; Jiang et 
al., 2013) 
PF3D7_0508100 
 
PBANKA_1107700 SET SET domain protein, putative (SET9) i) Ankyrin repeats 
ii) Fis1 C-terminal 
tetratricopeptide repeat 
iii) DUF2198 
(Jiang et al., 2013) 
PF3D7_1221000 
 
PBANKA_1436200 SET Histone-lysine N-methyltransferase, 
H3 lysine-4 specific (SET10) $ 
i) SET-domain 
ii) PHD-domain 
(Volz et al., 2012) 
PF3D7_1211600 
 
PBANKA_0610100 HKDM Lysine-specific histone demethylase 
1, putative (LSD1) 
 
i) PHD-domain 
ii) PHD-like zinc-binding 
domain 
iii) FAD-binding domain (x2) 
iv) NAD(P)-binding 
Rossmann-like domain 
(Cui et al., 2008; Volz 
et al., 2010; Jiang et 
al., 2013) 
PF3D7_0801900 
 
PBANKA_1228300 
 
HKDM Lysine-specific histone 
demethylase, putative (LSD2) 
i) FAD-NAD(P)-binding 
domain 
ii) NAD(P)-binding 
Rossmann-like domain 
iii) FAD-binding domain (x2) 
(Poran et al., 2017) 
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iv) Alanine 
dehydrogenase/PNT, C-
terminal domain 
PF3D7_0809900 
 
---- HKDM JmjC domain-containing protein, 
putative (JmjC1) 
i) JmjC domain (x2) 
ii) JmjN domain 
iii)  C5HC2 -like zinc finger 
domain 
(Cui et al., 2008; Volz 
et al., 2010; Jiang et 
al., 2013; Rono et al., 
2017) 
PF3D7_0602800 
 
PBANKA_0101600 HKDM JmjC domain-containing protein, 
putative (JmjC2) 
i) Cupin-like domain (Cui et al., 2008; 
Jiang et al., 2013; 
Rono et al., 2017) 
PF3D7_1426200 
 
PBANKA_1018400 
 
Class I PRMT Protein arginine N-
methyltransferase 1 (PRMT1) 
i) Arginine 
methyltransferase 
domain 
(Horrocks et al., 2009) 
PF3D7_0811500 
 
PBANKA_1426000 
 
Class I PRMT Histone-arginine methyltransferase 
CARM1, putative 
i) Arginine 
methyltransferase 
domain 
(Horrocks et al., 2009) 
PF3D7_1361000 
 
PBANKA_1137100 
 
Class II PRMT protein arginine N-
methyltransferase 5, putative 
(PRMT5) 
i) PRMT5 arginine-N-
methyltransferase 
domain 
ii) PRMT5 TIM barrel 
domain 
iii) PRMT5 oligomerisation 
domain 
(Horrocks et al., 2009) 
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PF3D7_1003300 PBANKA_1201700 
 
GNAT N-terminal acetyltransferase A 
complex catalytic subunit ARD1, 
putative (ARD1) 
i) Acetyltransferase 
domain 
(Kanyal et al., 2018) 
PF3D7_0109500 PBANKA_0204100 
 
GNAT N-acetyltransferase, putative i) Acetyltransferase 
domain 
ii) FR-47-like domain 
(Kanyal et al., 2018) 
PF3D7_0805400 PBANKA_1225200 
 
GNAT Acetyltransferase, putative i) Acetyltransferase 
domain 
ii) RimL domain 
(Kanyal et al., 2018) 
PF3D7_0629000 PBANKA_1127600 
 
GNAT N-acetyltransferase, putative i) Acetyltransferase 
domain 
(Kanyal et al., 2018) 
PF3D7_1437000 PBANKA_0611800 
 
GNAT N-acetyltransferase, putative i) Acetyltransferase 
domain 
ii) NAT domain 
(Kanyal et al., 2018) 
PF3D7_0823300 PBANKA_0707300 
 
GNAT Histone acetyltransferase GCN5 
(GCN5)  
i) Acetyltransferase 
domain 
ii) Bromodomain 
(Fan, An and Cui, 
2004b, 2004a; Kumar 
et al., 2017; Kanyal et 
al., 2018) 
PF3D7_1323300 PBANKA_1338500 
 
GNAT Acetyltransferase, GNAT family, 
putative 
i) Acetyltransferase 
domain 
(Kanyal et al., 2018) 
PF3D7_1227800 PBANKA_1442500 
 
GNAT Elongator complex protein 3, 
putative (ELP3) 
i) Radical SAM/HAT domain (Stilger and Sullivan, 
2013; Kanyal et al., 
2018) 
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PF3D7_1020700 PBANKA_0504900 
 
GNAT Histone acetyltransferase, putative i) Acetyltransferase 
domain 
ii) Helicase domain 
iii) tRNA-binding domain 
iv) tRNA(Met) cytidine 
acetyltransferase TmcA 
domain 
(Kanyal et al., 2018) 
PF3D7_1118600  PBANKA_0929500 
 
MYST Histone acetyltransferase (MYST) $ i) Acetyltransferase 
domain 
ii) Chromodomain-like 
domain 
iii) C2HC-type zinc finger 
domain 
(Miao et al., 2010; 
Kanyal et al., 2018) 
PF3D7_0416400 PBANKA_0718400 
 
GNAT Histone acetyltransferase, putative 
(HAT1) 
i) HAT1 domain (x2) (Horrocks et al., 2009) 
PF3D7_1472200 PBANKA_1335400 
 
HDAC Class II Histone deacetylase, putative 
(HDA1) 
i) Histone deacetylase 
domain (x3)  
ii) Ankyrin repeats 
(Kanyal et al., 2018) 
PF3D7_0506600 PBANKA_1106200 
 
HDAC Class II Histone deacetylase, putative, 
pseudogene 
i) Histone deacetylase 
domain 
(Kanyal et al., 2018) 
PF3D7_1008000 PBANKA_1206200 
 
HDAC Class II Histone deacetylase 2 
(HDA2/HDAC2) $ 
i) Histone deacetylase 
domain (x3)  
ii) DUF2981 domain 
iii) Inositol polyphosphate 
kinase domain 
(Coleman et al., 2014; 
Kanyal et al., 2018) 
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PF3D7_1023900 PBANKA_0508100 
 
Unclassified Chromodomain-helicase-DNA-
binding protein 1 homolog, putative 
(CHD1) 
i) Chromo/chromo-shadow 
domain-like 
ii) Helicase family ATP-
binding domain 
iii) SNF2-related, N-terminal 
domain 
iv) Helicase domain 
(Kanyal et al., 2018) 
PF3D7_0925700 PBANKA_0826500 
 
HDAC Class I Histone deacetylase 1 (HDAC1) i) Histone deacetylase 
domain 
(Joshi et al., 1999; 
Chaal et al., 2010; 
Kanyal et al., 2018) 
PF3D7_1328800 PBANKA_1343800 
 
HDAC Class III Transcriptional regulatory protein 
SIR2A (SIR2A) $ 
i) DHS-like NAD/FAD 
binding/sirtuin domain 
(Merrick et al., 2010; 
Zhu et al., 2012; 
Mancio-Silva et al., 
2013; Kanyal et al., 
2018) 
PF3D7_1451400 PBANKA_1315100 
 
HDAC Class III Transcriptional regulatory protein 
SIR2B (SIR2B) $ 
i) Histone deacetylase 
domain (x2)  
(Tonkin et al., 2009; 
Petter et al., 2011; 
Merrick et al., 2012; 
Kanyal et al., 2018) 
PF3D7_1117100 
 
PBANKA_0930900 UCH  Deubiquinating/deneddylating 
enzyme (UCH54) $ 
i) UCH family 1 domain 
(x2) 
ii) Menin-binding domain 
(Artavanis-Tsakonas et 
al., 2006; Cui and 
Miao, 2010) 
PF3D7_1460400 PBANKA_1324100 
 
UCH Ubiquitin carboxyl-terminal 
hydrolase isozyme L3 (UCHL3) $ 
i) UCH family 1 domain 
 
(Artavanis-Tsakonas et 
al., 2010; Cui and 
Miao, 2010) 
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PF3D7_1414400 
 
PBANKA_1028300 
 
PP1 Serine/threonine protein 
phosphatase PP1 
i) Calcineurin-like 
phosphoesterase domain 
ii) Serine-threonine protein 
phosphatase N-terminal 
domain 
(Shimada et al., 2010; 
Fréville et al., 2012) 
PF3D7_1220900 
 
PBANKA_1436100 
 
HP1 Heterochromatin protein 1 (HP1) $ i) Chromo domain (Brancucci et al., 
2014) 
PF3D7_1033700 
 
PBANKA_0517500 
 
BDP Bromodomain protein 1 (BDP1) $ i) Ankyrin repeat region 
ii) Bromodomain 
(Josling et al., 2015) 
PF3D7_1212900 
  
 
PBANKA_1428900 
 
BDP Bromodomain protein 2, putative 
(BDP2) 
i) Bromodomain (Josling et al., 2015) 
 
Supplemental Table S1: Proven and putative epigenetic modifiers in Plasmodium spp. This table provides a list of all of the epigenetic modifiers so far 
identified in P. falciparum and P. berghei ANKA (where present). The P. berghei ANKA genome does not encode for a SET2 histone lysine demethylase or a 
JmjC1 histone lysine demethylase, though both are present in P. falciparum. Gene identifiers (from PlasmoDB) are provided in the first and second columns; 
the protein superfamily into which the modifying enzymes are classified are provided in the third column; the fourth column contains the PlasmoDB name 
provided for epigenetic modifier; and the fifth and sixth columns provide a list of protein domains for a given epigenetic modifier with references to studies 
in which the protein was identified or characterized (characterised in Plasmodium or other organism). A “$” symbol next to the name of the protein in the 
fourth column indicates that the protein has been characterised in a Plasmodium spp. parasite previously. Only one putative serine/threonine phosphatase 
(PP1) has been listed as this is the only Plasmodium phosphatase with a homologous protein that has been demonstrated as having an effect on histone 
phosphorylation (Shimada et al., 2010). Table generated using PlasmoDB [up-to-date as of the 4th of March, 2018] (The EuPathDB Project Team, 2018). 
HKMT: histone lysine methyltransferase; SET: Su(var)3-9, Enhancer of zeste, and Trithorax; HKDM: histone lysine demethylase; PRMT: Protein arginine 
methyltransferase; PP1: Protein phosphatase 1; GNAT: Gcn5-related N-acetyltransferase; HAT: histone acetyltransferase; MYST: MOZ, Ybf1/Sas3, Sas2, 
and Tip60; HDAC/HDA: Histone deacetylase; ELP: Elongator complex protein; SIR2: Silencing information regulator 2; CHD: Chromodomain helicase DNA-
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binding; SNF2: Sucrose non-fermentation 2; DUF: Domain of Unknown Function; TmcA: tRNA(met) cytidine Acetyltransferase; NAT: N-acetyltransferase; 
NAD: nicotinamide adenine dinucleotide; FAD: flavin adenine dinucleotide; DHS: deoxyhypusine synthase; UCH: ubiquitin C-terminal hydrolase.; Chromo: 
Chromatin Organisation Modifier; SAM: S-adenosylmethionine; JmjC: Jumonji C-terminal; JmjN: Jumonji N-terminal; CARM1: Coactivator-Associated Arginine 
Methyltransferase 1; Fis1: Mitochondrial Fission protein 1; BDP: Bromodomain protein.      
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Supplemental Images S1A-S1M: Chapter 3 linear plasmid maps. 
 
 
Supplemental Image 1A: The “820” background line. To create a P. berghei ANKA line in which 
male and female gametocytes could be identified by fluorescence, a drug-selectable cassette was 
inserted at the p230p locus (site p230pI) (an upstream paralogue of the P230 6-cysteine male 
gametocyte surface protein; PBANKA_0306000) of the high-producer (HP) P. berghei ANKA line, 
clone15cy1 (Janse et al., 1989; Ponzi et al., 2009). i) shows linearised plasmid pL1186. 
Complementary p230pI sequences flanked the drug selection and fluorescent marker cassette (p230p’ 
sequences). A fused human dihydrofolate reductase gene (hdhfr) with a Pyrimethamine resistance-
conferring single nucleotide polymorphism (SNP), and bifunctional yeast cytosine deaminase-uridyl-
phosphoribosyltransferase (ycfu) acted as the positive/negative drug selection gene. This fused 
hdhfr::yfcu was driven by the 5’ promoter of the constitutively-expressed P. berghei elongation 
factor 1 alpha (5’eef1⍺) (bidirectional promoter of genes PBANKA_1133300 and PBANKA_1133400), 
and flanked by identical 3’UTRs of the mutated P. berghei DHFR-TS gene (pbdhfr-ts 3’UTR). To 
produce RFP-fluorescent female gametocytes and GFP-fluorescent male gametocytes, an enhanced 
green fluorescent protein (egfp) sequence was driven by the promoter of the highly male gametocyte-
specific heavy dynein chain protein (PBANKA_0416100). A red fluorescent protein sequence (rfp) was 
similarly driven by the promoter of the female gametocyte-specific LCCL-domain containing gene, 
Ccp2 (ccp2) (PBANKA_1319500). This fused fluorescence cassette was then flanked by the 3’ UTRs of 
the P. berghei calmodulin gene (3’cam; PBANKA_0514800) and p48/45 gene (3’ 48/45). ii) and iii) 
illustrate the p230p locus (site p230pI) of P. berghei parasites before and after integration of the 
plasmid construct. Under Pyrimethamine drug selection, wild-type (WT) parasites such as ii) will be 
killed by the drug, leaving only parasites with integrated selection cassettes such as iii). The final 
p230p locus in iv) depicts the “820” background clonal line after negative selective with 5-
fluorocytosine (5-FC), which has led to a recombination event in which the drug selectable cassette 
has been lost, but the fluorescent GFP/RFP cassette remains.        
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Supplemental Image 1B: The P. berghei ANKA “early gametocyte” (“PbEGAM”) background line. 
In i) is the linearised pG403 plasmid, in which an rfp sequence is driven by the promoter of a recently 
identified genetic marker for early gametocytogenesis (RFP signal at 8-12 hpi), PBANKA_1018700 
(Sinha et al., 2014; Rebecca S. Lee, Waters and Brewer, 2018). In this plasmid, both drug selection 
and fluorescent cassettes are flanked by sequences homologous to a second site of the p230p locus: 
p230pII. Between these homology arms are the hdhfr::yfcu positive/negative drug selectable 
markers, driven by the 5’eef1⍺	 promoter, and flanked by two identical pbdhfr-ts 3’UTRs. The 
PBANKA_1018700 promoter::rfp fluorescent cassette is contained between two non-identical 3’UTRs: 
the first being the second pbdhfr-ts 3’UTR of the drug selectable cassette, with a 3’48/45 UTR 
located downstream of rfp. This DNA construct was designed so as to be inserted into the p230p locus 
of the P. berghei ANKA 507 background line shown in ii), a line in which GFP is constitutively 
expressed throughout the life cycle (Janse, Ramesar and Waters, 2006). In ii), the p230pI and p230pII 
sites of the P. berghei 507 line are shown. The p230pII site is akin to WT P. berghei ANKA, while the 
p230pI site contains a GFP reporter sequence (gfp) that is driven by the constitutively-expressed 
pbeef1⍺	promoter, and flanked downstream by a pbdhfr-ts 3’UTR. iii) shows the 507 p230pII site 
after integration of the linear plasmid (i), but before negative selection (creating P. berghei ANKA 
line G1137cl2). In iv), the full p230pI and p230pII sites are shown as they would appear after negative 
selection with 5-FC, and after the drug selection cassette has been removed by recombination.            
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Supplemental Image 1C: The P. berghei ANKA auxin-inducible degron (“AID”) background line. In 
i), linearised plasmid pG230 is depicted. This plasmid is designed for integration into the p230pI site 
of the P. berghei HP line genome. Two p230p’ homology arms flank a 5’eef1⍺	promoter-driven 
hdhfr::yfcu cassette (again flanked by identical pbdhfr-ts 3’UTRs), and a DNA sequence containing 
the ‘F-box’ transport inhibitor response protein 1 (TIR1) gene sequence from Oryza sativa (ostir1) 
(Philip and Waters, 2015). This ostir1 sequence is driven by a potent, constitutive promoter of P. 
berghei heat shock protein 70 (5’hsp70) (PBANKA_0711900) (Manzoni et al., 2015). The ostir1 
sequence is also bound to 9 repeats of the human c-myc tag (EQKLISEEDL) (9xmyc) and, further 
downstream, to a p48/45 3’UTR (3’48/45). ii) and iii) depict the p230pI locus of the P. berghei ANKA 
HP clonal line before and after integration of the linearised plasmid. iii) also depicts the p230pI site 
as it would appear in parasites after positive selection with Pyrimethamine (line G615cl1). In iv), the 
p230p locus of the “AID” background line is shown after negative drug selection with 5-FC. In this 
clonal line, the ostir1::9xmyc sequence is constitutively expressed throughout the P. berghei life 
cycle, enabling conditional degradation of AID-tagged proteins.   
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Supplemental Image 1D: The P. berghei ANKA “AID 820” background line. Using a near-identical 
plasmid to that shown in S3 i), the AID 820 background line was designed so as to allow both 
conditional degradation and the ability to monitor male and female gametocytogenesis 
simultaneously in P. berghei ANKA. In i), linearised plasmid pG841 is shown, with homology arms 
designed for integration of the DNA construct into the p230pII site of the 820 background line. This 
plasmid contains the previously shown hdhfr::yfcu drug selection cassette, with a downstream 
ostir1::9xmyc fusion gene that is driven by a 5’hsp70 promoter for constitutive expression. At the 3’ 
end of this fused sequence is the 3’UTR of PBANKA_1318600 (3’ pb-633-), a previously unused 3’ UTR 
in the AID or 820 background lines (Braks et al., 2008). Usage of this 3’UTR prevented unwanted 
recombination with other sequences to be integrated into the P. berghei ANKA genome. To make this 
background line, the pG841 linearised plasmid (i) was transfected into the 820 background line. ii) 
depicts both the p230pI and p230pII sites of the “WT” 820 background line. iii) shows the p230pII site 
after integration of pG841 and positive drug selection with Pyrimethamine (creating line G1448cl1). 
In iv), the final conformation of the p230pI and p230pII sites after negative drug selection with 5-FC 
is shown, creating line G1448cl1m0cl1 (the “AID 820” line) after cloning by limiting dilution.  
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Supplemental Image 1E: P. berghei ANKA line G1512: AID-tagged heterochromatin protein 1 
(HP1). i) shows linearised plasmid pG438, designed for single-crossover homologous recombination 
with the endogenous P. berghei ANKA HP1 sequence (PBANKA_1436100) (Carvalho and Ménard, 2005). 
A sequence of ~1500 bp of the HP1 gene (and some upstream sequence) was inserted into an AID-
containing background plasmid (pG364), upstream of an AID::HA tag. The final stop codon of the 
gene-of-interest (GOI) coding sequence (TAG, TAA, or TGA) was removed. A 3’UTR of the P. berghei 
ANKA p48/45 gene (3’pb48/45) was placed downstream of the AID::HA tag. Downstream of this 
tagging sequence, a bidirectional P. berghei eef1⍺ promoter controls both the expression of a positive 
selection sequence (hdhfr, with pbdhfr 3’UTR), and a fluorescent mCherry protein (mCherry, with a 
calmodulin gene 3’UTR (3’cam)). The pG438 plasmid shown in i) is linearised by restriction enzyme 
digestion with Hpa1, this being because both the HP1 endogenous sequence, and the pG364 plasmid 
backbone, contain only one Hpa1 restriction site which can cut the plasmid at one unique point to 
facilitate integration into the P. berghei AID background line. ii) shows the p230pI locus of the AID 
background line (expressing ostir1::9xmyc), and the WT HP1 gene. In iii), both the p230pI locus and 
the AID::HA-tagged HP1 gene are shown as they would appear following positive selection with 
Pyrimethamine. A residual ampicillin resistance sequence (amp) remains in the plasmid backbone 
after integration. In this case, the hdhfr drug selection marker was not removed by negative selection 
after integration of the plasmid (as a fused hdhfr::yfcu cassette was not used).   
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Supplemental Image 1F: P. berghei ANKA line G1513: AID-tagged histone deacetylase 1 (HDAC1). 
i) depicts the linearised pG439 single-crossover plasmid. Like pG438 (S1E i)), the pG364 background 
vector containing a hdhfr positive drug selection cassette and P. berghei eef1⍺ promoter-driven 
mCherry tag was used, though in this case, the HDAC1 protein (PBANKA_0826500) was tagged at the 
3’ end with the AID::HA fused protein. In this case, the circular plasmid was linearised by restriction 
digest with PmlI, leaving an approximate 750 bp fragment (without stop codon) to integrate into the 
WT HDAC1 protein by single-crossover homologous recombination. In ii), the AID background line 
p230pI site is shown, located upstream of the WT HDAC1 gene (PBANKA_0826500). After transfection 
and positive drug selection, the final AID-tagged HDAC1 line would appear as in iii) (P. berghei ANKA 
line G1513.  
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Supplemental Image 1G: P. berghei ANKA line G1514: AID-tagged histone deacetylase 2/inositol 
phosphate kinase 1 (HDAC2/IPK1). i) is a diagrammatic representation of the linearised pG440 
plasmid (not to scale), showing an adaptation of the pG364 background vector to tag the whole 
HDAC2/IPK1 (a fused protein; PBANKA_1206200) with an AID::HA tag at its C-terminus. As is necessary 
for C-terminal tagging, the HDAC2/IPK1 stop codon has been removed and, in this case, the unique 
restriction site for BglII was used to linearise the DNA construct. ii) depicts the ostir1::9xmyc-
expressing sequence at the p230pI site, with the WT PBANKA_1206200 located downstream. In iii), 
the final, positively-selected P. berghei ANKA G1514 line is shown, with ostir::9xmyc expressed at 
the p230pI locus and the HDAC2/IPK1 protein tagged with AID::HA. G1514 parasites can be drug-
selected (eef1⍺ promoter-driven hdhfr sequence) or separated by FACS based on mCherry 
fluorescence (eef1⍺ promoter-driven mcherry sequence).  
 
 
 Supplemental Information  
 16 
 
 
Supplemental Image 1H: P. berghei ANKA line G1516: an AID-tagged histone deacetylase 1 
(HDA1). i) depicts the linearised pG474 plasmid vector for the C-terminal tagging of HDA1 
(PBANKA_1335400) with an AID:HA fused tag. In the absence of an endogenous unique restriction site 
within the HDA1 sequence, a SalI restriction site was added during amplification of the HDA1 
homology arms by PCR. Restriction digest with SalI produced a linearised pG474 plasmid with two 
homologous sequences of ~850 bp at either side of the single-crossover cassette (the pG364 
background plasmid once more). As usual, the final HDA1 stop codon was removed. In ii), the p230pI 
site of the AID background parasite line is shown, with the WT HDA1 gene located downstream 
(PBANKA_1335400). iii) depicts the final p230pI site and AID::HA-tagged HDA1 gene, creating the P. 
berghei ANKA G1516 line after positive selection with Pyrimethamine.  
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Supplemental Image 1I: P. berghei ANKA line G1517: an AID-tagged putative histone deacetylase 
(HDA, putative, a.k.a “HDAP”). i) shows the linearised pG475 plasmid, based on the AID::HA tagging 
vector, pG364. In this case, as in the case of HDA1 (S1H), a SalI restriction site was inserted into the 
HDAP sequence during amplification of homology arms for single-crossover homologous 
recombination. The stop codon of HDAP was removed and so the AID::HA sequence is translated at 
the C-terminus of HDAP. A bidirectional eef1⍺ promoter again drives both a hdhfr sequence, and an 
mCherry sequence for isolation and selection of the successfully-tagged P. berghei parasites. In ii), 
the p230pI site of the P. berghei AID background line is depicted with the WT HDAP sequence shown 
downstream (PBANKA_1106200). The final, positively-selected parasites (named P. berghei ANKA line 
G1517) have a p230pI site and AID::HA-tagged HDAP gene as depicted in iii).  
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Supplemental Image 1J: P. berghei ANKA line G1623: AID- and BFP- tagged heterochromatin 
protein 1 (HP1). i) depicts the linearised pG910 plasmid, an AID::HA-tagging vector for the HP1 gene 
of P. berghei ANKA. Unlike the AID::HA-tagging plasmid shown in S1E i), this plasmid was made using 
the background tagBFP-containing vector, pG472. In this case, HP1 was uniquely cut again by Hpa1 
restriction digest, and the stop codon of the HP1 gene sequence had been removed for expression of 
the AID::HA tag at the HP1 C-terminus. In the plasmid, pG910, a bidirectional eef1⍺ promoter drives 
a hdhfr sequence (to enable positive drug selection with Pyrimethamine), and the tagBFP sequence 
with a P. berghei ANKA calmodulin 3’UTR (3’cam). This linearised plasmid was then transfected into 
the 820 P. berghei background line, the p230pI and p230pII sites of which is shown in ii). The WT HP1 
gene (PBANKA_1436100) is shown downstream of the GFP/RFP-containing locus (as the p230p locus 
is located on chromosome 3 (of 14) in the P. berghei genome (PBANKA_0306000)). In iii), the final 
G1623 line is shown after positive selection with Pyrimethamine. The male gametocyte-specific heavy 
dynein chain (PBANKA_0416100) promoter drives egfp expression. The promoter of the female 
gametocyte-specific LCCL-domain containing gene, Ccp2 (ccp2) (PBANKA_1319500) drives the red 
fluorescent protein sequence (rfp), and the integration of the AID::HA-tagged HP1 vector should 
produce constitutive expression of the blue fluorescent protein (BFP) reporter sequence (tagBFP). 
The eef1⍺ promoter sequence also drives the hdhfr positive drug selection sequence, with 
ostir1::9xmyc constitutively expressed at the p230pII site.     
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Supplemental Image 1K: P. berghei ANKA line G1624: AID- and BFP- tagged histone deacetylase 
1 (HDAC1). i) depicts the linearised pG911 plasmid which differs from that of the pG439 plasmid 
shown in S1F i) at the fluorescent reporter sequence. Using the pG472 background plasmid, pG911 
was made so that P. berghei parasites containing an AID::HA-tagged HDAC1 protein will exhibit BFP 
fluorescence in background parasites that already contain the male and female gametocyte-specific 
GFP/RFP expression cassette. In ii), the p230pI and p230pII sites of the “AID 820” line are shown, 
positioned upstream of the WT HDAC1 gene. Upon integration of the plasmid and positive drug 
selection with Pyrimethamine, the new G1624 parasites contain the background sequences as shown 
in iii). This line could then be used to monitor the effect of HDAC1 conditional degradation on male 
and female gametocytes separately.  
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Supplemental Image 1L: Histone acetyltransferase 1 (HAT1) knockout in the P. berghei ANKA 820 
line. Unlike plasmids used to tag GOIs by single-crossover homologous recombination, gene knockout 
plasmids obtained from the PlasmoGEM database (Schwach et al., 2015) contain long homology arms 
to replace a GOI with a hdhfr::yfcu drug selection cassette. i) shows the linearised pG856 plasmid 
(PbGEM 236544) after restriction digest with NotI. All PlasmoGEM DNA constructs are bacteriophage 
N15-based pJAZZ OK vectors that are linearised at a NotI restriction site (Pfander et al., 2013). To 
target the HAT1 gene (PBANKA_0718400), a hdhfr::yfcu drug selection cassette (driven by a 5’eef1⍺ 
promoter and flanked by identical pbdhfr-ts 3’UTRs) is placed between a 2088 bp region of the 
upstream gene (PBANKA_0718300) and a 1730 bp sequence homologous to the downstream gene 
(PBANKA_0718500). In ii), the p230pI site and WT HAT1 gene are depicted as they would be in the 
“WT” 820 line prior to integration of the pG856 plasmid. iii) then shows the p230pI site and the GOI 
(HAT1) site as it would appear after positive drug selection and cloning. For the purposes of the 
present study, negative selection with 5-FC to remove the hdhfr::yfcu cassette was not necessary. 
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Supplemental Image 1M: Histone acetyltransferase 1 (HAT1) knockout in the P. berghei ANKA 
PbEGAM line. As in S1L, the pG856 PlasmoGEM knockout vector was used to replace the HAT1 gene 
with a hdhfr::yfcu drug-selectable cassette (i). In this case, the linearised pG856 plasmid was 
transfected into the PbEGAM “early gametocyte” P. berghei ANKA line, depicted in ii). In ii), the 
p230pI and p230pII integration sites of the p230p locus are shown. In p230pI, a constitutive pbeef1⍺ 
promoter drives a gfp fluorescent reporter sequence (with a pbdhfr-ts 3’UTR). At the adjacent, 
downstream p230pII site, an rfp sequence is driven by the PBANKA_1018700 promoter (with 
fluorescence in gametocytes seen from 8-12 hpi) (Rebecca S Lee, Waters and Brewer, 2018). Further 
downstream again is the HAT1 gene (PBANKA_0718400). The nearest upstream and downstream genes 
are also depicted as the homology arms of the PlasmoGEM vector span these regions. Following 
transfection of the linearised plasmid and positive drug selection, the final p230p locus and HAT1 
region of the P. berghei genome is arranged as in iii). As with other KO experiments in this study, 
negative drug selection was not required for these KO lines.     
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Supplemental Image 1N: Histone deacetylase 1 (HDA1) knockout in the P. berghei ANKA 820 line. 
As in S1L, knockout (KO) of putative histone deacetylase 1 (HDA1) (PBANKA_1335300) was undertaken 
using a PlasmoGEM vector. In i), HDA1 KO plasmid pG854 (PbGEM 250987) is depicted. As was the 
case with the HAT1 KO plasmid, the long homology arms of pG854 encompass 1733 bp of the upstream 
gene (PBANKA_1335300) and 3076 bp of the downstream gene (PBANKA_1335500) to facilitate double-
crossover homologous recombination with the WT HDA1 gene. When integrated into the background 
P. berghei ANKA line, the HDA1 coding region is replaced by a hdhfr::yfcu drug selection cassette. 
ii) shows the p230pI site and the “WT” HDA1 locus of the 820 line before transfection. In iii), the 
linearised pG854 has been integrated into the 820 genome and positive drug selection with 
Pyrimethamine carried out, leaving behind the GFP/RFP male/female gametocyte fluorescent 
reporters at p230pI and a hdhfr::yfcu cassette in place of the HDA1 gene.      
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Supplemental Image 1O: Histone deacetylase 1 (HDA1) knockout in the P. berghei ANKA PbEGAM 
line. As in S1N, the pG854 PlasmoGEM vector was used for the knockout (KO) of HDA1 by double-
crossover homologous recombination (i). In ii), the P. berghei ANKA PbEGAM p230pI and p230pII sites 
of the p230p integration locus are shown, with the HDA1 gene and adjacent genes depicted 
downstream. Following transfection of the NotI-cut, linearised pG854 plasmid and positive drug 
selection, the p230p locus and HDA1 locus appear as depicted in iii). In the resultant line (G1579), 
no negative selection was necessary as no further genetic manipulation of the parasite line was 
warranted in this study.   
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Supplemental Section S1 
 
S1.1 The histone 4 (H4) of P. berghei 
 
Of all eukaryotic histone types and variants, histone 4 (H4) is most conserved (Malik 
and Henikoff, 2003), and this conservation of the H4 sequence remains in 
Plasmodium spp. (Figure S1). Using a combination of Clustal multiple sequence 
alignment (Sievers and Higgins, 2014) and basic local alignment search tool (BLAST) 
for protein sequences (blastp) (Altschul et al., 1990), the P. berghei ANKA H4 
peptide sequence was compared to those of four available human-infective 
Plasmodium species (P. vivax, P. knowlesi, P. malariae, and P. falciparum) alongside 
H4 amino acid sequences from the mouse (Mus musculus), rat (Rattus norvegicus), 
and human (Homo sapiens sapiens) (Figure S1). As can be seen in Figure S1, the 
amino acid sequences of all Plasmodium spp. are identical. Between Plasmodium 
spp. and mammals, the majority of amino acids are also conserved, with all but two 
amino acid changes being between residues with strongly similar physiochemical 
properties (based on a PAM (partitioning around medoids) 250 matrix scoring system 
of protein similarity (Gonnet, Cohen and Benner, 1992; Pearson, 2013)). 
Furthermore, each H4 sequence is exactly 103 amino acids (aa) in length.  
 
Taking P. berghei ANKA H4 as a reference, protein-protein blastp alignment revealed 
92% sequence identity to the H4 sequences of M. musculus, R. norvegicus, and H. 
sapiens sapiens (blastp alignments not shown). In fact, all mammalian H4 sequences 
were identical.      
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Figure S1: Clustal alignment of Plasmodium spp. histone 4 (H4). The above alignment of histone 4 
amino acid sequences was carried out using Clustal Omega (Sievers and Higgins, 2014) and shows a 
comparison of histone 4 peptide sequences from P. berghei ANKA, P. vivax isolate Salvador 1 (Sal-1), 
P. knowlesi macaque-adapted experimental strain H, P. malariae Uganda 01 (UG01) isolate, P. 
falciparum strain 3D7, the mouse Mus musculus, the rat Rattus norvegicus strain, and Homo sapiens  
sapiens (P. ovale curtisi/wallikeri H4 sequence data unavailable at time of writing [07-02-18]). 
Peptides are distinguished from one another by colour, and the positions of lysines (often the target 
for post-translational modifications) are further indicated by a star (★) above their amino acid letter 
(K). In Clustal, an asterisk (*) below an aligned amino acid indicates that the amino acid is fully 
conserved. A colon (:) underneath an aligned amino acid indicates conservation between residues 
with strongly similar properties (scoring an equivalent of >0.5 the Gonnet PAM 250 matrix (Pearson, 
2013)). A full stop/period (.) below an aligned amino acid indicates conservation of residues with 
weakly similar properties (roughly equivalent to a score of >0 but <0.5 on the Gonnet PAM 250 matrix 
(Pearson, 2013)). No symbol beneath an aligned amino acid signifies that there is no conservation of 
the amino acid or exchange for an amino acid with similar properties.  
 
S1.2 The canonical histone 3 (H3) of P. berghei  
 
In mammals, two canonical, non-centromeric H3 histones are expressed (designated 
H3.1 and H3.2) and differ in their binding partners during DNA synthesis (Latreille et 
al., 2014; Maehara et al., 2015). At the amino acid level, all H3.1 and H3.2 peptides 
are 136 aa in length, with the H3.1 and H3.2 sequences differing at only one point. 
At position 96 of the 136 aa sequence (not counting the first methionine), H3.2 
contains a serine, with the H3.1 sequence containing a cysteine at the same position 
(Figure S2 (A)). Figure S2 (A) shows a Clustal alignment of the human H3.1 and H3.2 
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protein sequences, though this same amino acid substitution is conserved between 
H3.1 and H3.2 sequences of both M. musculus (protein accessions P68433.2 
(H31_MOUSE) and P84228.2 (H32_MOUSE)) and R. norvegicus (protein accessions 
Q6LED0.3 (H31_RAT) and D3Z80J (D3Z80J_RAT)) (all alignments not shown).  
 
In P. berghei ANKA, only one canonical histone 3 (H3) is present (encoded for by 
PBANKA_0108800) and it shows 93% sequence identity to both the H3.1 and H3.2 
protein sequences of mammalian H3, with blastp total scores differing by one digit 
(total blastp scores were 260 and 259 for H3.2 and H3.1 respectively) (blastp results 
not shown). As a result of an overall higher total score, Plasmodium spp. sequences 
were aligned to the mammalian H3.2 protein sequences (Figure S2 (B)).  
 
In P. berghei ANKA, at position 96 (the position that defines H3.1 and H3.2), the 
serine(S) and cysteine (C) residues are replaced by an alanine (A), a change that is 
conserved among all Plasmodium spp. Taking all Plasmodium H3 protein sequences 
alone, only one of the six aligned sequences showed a deviation from the others 
(Figure S2 (B)). Though the H3 sequences of P. berghei, P. falciparum, P. vivax, P. 
ovale curtisi, and P. malariae were 100% identical, the canonical H3 of P. knowlesi 
strain H showed a number of amino acid substitutions, with 94% sequence identity 
to the other Plasmodium spp. overall (blastp results not shown). The changes to the 
canonical P. knowlesi H3 are often between amino acids that share similar 
physiochemical properties, though it should be noted that among these changes is 
the substitution of an arginine (R) to a lysine (K) at position 53, a change that may 
have downstream post-translational consequences. Notably, R53 is conserved 
between all mammalian and Plasmodium spp. H3 sequences, with P. knowlesi GH01 
being the only outlier (Figure S2 (B)).   
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Figure S2: Clustal alignment of Plasmodium spp. canonical histone 3 (H3). In (A) above, Clustal 
alignment of the human H3.1 and H3.2 protein sequences is shown, with the cysteine (C) to serine 
(S) substitution clearly indicated by a period (.) beneath the residue of interest. In (B) alignment of 
histone 4 amino acid sequences is shown, as carried out using Clustal Omega (Sievers and Higgins, 
2014). The alignment in this case includes comparison of canonical histone 3 peptide sequences from 
P. berghei ANKA, P. vivax isolate Salvador 1 (Sal-1), P. knowlesi macaque-adapted experimental 
strain H, P. malariae Uganda 01 (UG01) isolate, P. falciparum strain 3D7, P. ovale curtisi Ghana 01 
isolate (Poc GH01), and the H3.2 protein sequences of M. musculus, R. norvegicus, and H. sapiens 
sapiens. Peptides are distinguished from one another by colour, and the positions of lysines (often 
the target for post-translational modifications) are further indicated by a star (★) above their amino 
acid letter (K). In Clustal, an asterisk (*) below an aligned amino acid indicates that the amino acid 
is fully conserved. A colon (:) underneath an aligned amino acid indicates conservation between 
 Supplemental Information  
 28 
residues with strongly similar properties (scoring an equivalent of >0.5 the Gonnet PAM 250 matrix 
(Pearson, 2013)). A full stop/period (.) below an aligned amino acid indicates conservation of residues 
with weakly similar properties (roughly equivalent to a score of >0 but <0.5 on the Gonnet PAM 250 
matrix (Pearson, 2013)). No symbol beneath an aligned amino acid signifies that there is no 
conservation of the amino acid or exchange for an amino acid with similar properties.  
   
It is important to note that during the time of writing, a second P. knowlesi sequence 
became available via PlasmoDB; the P. knowlesi Malayan strain Pk1A, for which a 
canonical histone 3 sequence had been assigned (PKNOH_S130206300) (Lapp et al., 
2017). Taking both P. knowlesi strain H and P. knowlesi Malayan strain Pk1A H3 
sequences; and aligning them to the other five H3 sequences shown in Figure S2 
(B), a Clustal alignment revealed that genome assembly using long-read Pacific 
Biosciences (PacBio) technology eliminated all but one amino acid change to the P. 
knowlesi H3 sequence (Figure S3). With this new assembly, P. knowlesi H3 is 
identical to the other Plasmodium spp. H3 sequences besides a single isoleucine (I) 
to methionine (M) substitution at position 32 (Figure S3).  
 
 
 
Figure S3: Realignment of Plasmodium spp. canonical histone 3 (H3) to include P. knowlesi 
Malayan strain Pk1A data. The image above shows Clustal alignment of canonical histone 3 peptide 
sequences from P. berghei ANKA, P. vivax isolate Salvador 1 (Sal-1), P. malariae Uganda 01 (UG01) 
isolate, P. falciparum strain 3D7, P. ovale curtisi Ghana 01 isolate (Poc GH01), P. knowlesi macaque-
adapted experimental strain H, and P. knowlesi Malayan strain Pk1A. In this alignment, the similarity 
of the P. knowlesi Malayan strain Pk1A H3 to other Plasmodium spp. H3 sequences can be seen. The 
clear disparity of the canonical H3 sequence of P. knowlesi strain H to the other species and the 
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Malayan isolate suggest that the original genome assembly underlying this protein sequence data may 
be flawed and that the H3 proteins of all Plasmodium spp. may be identical, or almost identical, in 
reality.  
In the above alignment the positions of lysines are indicated by a star (★) above their amino acid 
letter (K). In Clustal, an asterisk (*) below an aligned amino acid indicates that the amino acid is fully 
conserved. A colon (:) underneath an aligned amino acid indicates conservation between residues 
with strongly similar properties (scoring an equivalent of >0.5 the Gonnet PAM 250 matrix (Pearson, 
2013)). A full stop/period (.) below an aligned amino acid indicates conservation of residues with 
weakly similar properties (roughly equivalent to a score of >0 but <0.5 on the Gonnet PAM 250 matrix 
(Pearson, 2013)). No symbol beneath an aligned amino acid signifies that there is no conservation of 
the amino acid or exchange for an amino acid with similar properties.     
 
S1.3 The histone 3 variant (H3.3) of P. berghei  
 
In humans, there are a number of H3 variants outside of the ‘canonical’ H3.1 and 
H3.2 histones. There are two other ‘main’ H3 histones encoded for by the human 
genome: the replacement variant H3.3, and the centromere-specific H3, CENP-A 
(Shi, Wen and Shi, 2016). In humans, variant H3.3 can be incorporated into 
chromatin during replication at the cells synthesis phase (S-phase) or in a replication 
independent manner in non-dividing cells (Shi, Wen and Shi, 2016). The P. berghei 
ANKA genome also encodes for a H3.3 histone variant (PBANKA_1117100) that is 
identical to H3.3 sequences of 5 human-infective Plasmodium species, including 
both strains of P. knowlesi (Figure S4). 
 
When compared to mammalian H3.3 sequences (which are all identical to each 
other), P. berghei ANKA H3.3 differs at only 16 of 136 amino acids (89% sequence 
identity; blastp results not shown) (Figure S4). Most noticeable among these 
changes is the substitution of an arginine (R) for a lysine (K) at position 53, and a 5-
residue substituted region in the N-terminal H3.3 tail from positions 31-25, though 
amino acid changes are often between residues with similar physiochemical 
properties (Figure S4).  
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Figure S4: Clustal alignment of Plasmodium spp. variant histone 3.3 (H3.3). This image shows a 
Clustal alignment of variant histone 3.3 (H3.3) amino acid sequences from P. berghei ANKA, P. vivax 
isolate Salvador 1 (Sal-1), P. malariae Uganda 01 (UG01) isolate, P. falciparum strain 3D7, P. ovale 
curtisi Ghana 01 isolate (Poc GH01), P. knowlesi macaque-adapted experimental strain H, P. knowlesi 
Malayan strain Pk1A, and mammalian species, M. musculus, R. norvegicus, and H. sapiens sapiens. 
The H3.3 sequences are 100% identical among Plasmodium species, and 100% between mammals. The 
P. berghei ANKA H3.3 differs from the mammalian H3.3 at 16 of 136 aa (maintaining 89% sequence 
identity).   
In this image, lysines are again indicated by a star (★) above the amino acid letter (K). In Clustal, an 
asterisk (*) below an aligned amino acid indicates that the amino acid is fully conserved. A colon (:) 
underneath an aligned amino acid indicates conservation between residues with strongly similar 
properties (scoring an equivalent of >0.5 the Gonnet PAM 250 matrix (Pearson, 2013)). A full 
stop/period (.) below an aligned amino acid indicates conservation of residues with weakly similar 
properties (roughly equivalent to a score of >0 but <0.5 on the Gonnet PAM 250 matrix (Pearson, 
2013)). No symbol beneath an aligned amino acid signifies that there is no conservation of the amino 
acid or exchange for an amino acid with similar properties.  
 
S1.4 The canonical histone 2A (H2A) of P. berghei  
 
Among eukaryotic core histones, it is the H2A histone that exhibits the highest 
sequence divergence, with variants differing mostly at the C-terminus, including at 
 Supplemental Information  
 31 
the functionally important C-terminal docking domain (Bönisch and Hake, 2012). In 
P. berghei ANKA, the genome contains coding sequences for one core H2A histone 
(PBANKA_111700) and one H2A variant (H2A.Z) (PBANKA_1217600). Among 
Plasmodium spp. canonical H2A proteins, P. berghei ANKA H2A shares 100% sequence 
identity with canonical H2A sequences of P. vivax Sal-1, P. ovale curtisi GH01, and 
both P. knowlesi strains (strain H and Malayan strain Pk1A) (Figure S5). With regard 
to P. falciparum 3D7, the P. berghei ANKA H2A shares 98% sequence identity at 
amino acid level (blastp results not shown), with P. falciparum 3D7 substituting a 
serine (S) in place of a valine (V) at position 12, and 2 amino acid changes and the 
loss of a threonine residue at its C-terminus (Figure S5). In fact, the canonical H2A 
of P. falciparum 3D7 is the only H2A that is composed of 132 aa as opposed to 133 
aa in all other Plasmodium spp.  
 
Comparing P. berghei ANKA with P. berghei malariae UG01 however, reveals 98% 
amino acid sequence identity once more, with only 2 amino acid substitutions at the 
C-terminal tail of H2A (blastp results not shown). Surprisingly, these substitutions 
are not identical to those seen in P. falciparum 3D7, and the substitution of a valine 
(V) in P. malariae to a serine (S) in P. falciparum is present, as it is when comparing 
P. falciparum to the other Plasmodium spp. H2A sequences (Figure S5). Overall, P. 
malariae UG01 shares 97% sequence identity with P. falciparum 3D7 (blastp results 
not shown).  
 
When comparing the P. berghei ANKA canonical H2A to the amino acid sequences of 
mammalian canonical H2A, P. berghei H2A shares only 73% sequence identity with 
the human H2A type 1 protein sequence (encoded for by gene P0C0S8.2) and 73% 
sequence identity with the H2A type 1 sequences of M. musculus and R. norvegicus 
which are identical (blastp results not shown). Though canonical H2A subtypes in 
mammals are variable (Bönisch and Hake, 2012), there are noticeable differences 
to the N- and C- termini of the Plasmodium spp. H2A protein sequences (Figure S5). 
The lengthening of the Plasmodium spp. C-terminus by 3 amino acids, with a loss of 
lysine (K) residues at positions 125, 127 and 129 are particularly striking (Figure S5). 
In all eukaryotes, including Plasmodium spp., the C-terminus of H2A is located at 
the DNA entry/exit site of the nucleosome, making variations to this site a powerful 
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indicator of nucleosome stability and dynamics. This DNA entry/exit site is amenable 
to binding of DNA, binding to the H1 linker histone in higher mammals, and to binding 
by other interacting factors (Bönisch and Hake, 2012).  
 
At the N-terminus of canonical H2A, Plasmodium spp. H2A proteins have evolved to 
include additional lysine residues at positions 3, 10 and 20, with additional lysines 
again added at positions 35, 38 and 41. These latter changes are made at the exact 
point of the histone H2A loop 1 (positions 38-41), which interacts with the H4 loop 
2 to form a DNA-binding domain. Changes to the structure of loop 1 are linked to 
changes in centromeric targeting (Luger et al., 1997; Vermaak, Hayden and 
Henikoff, 2002; Bönisch and Hake, 2012). In Plasmodium spp., changes to the loop 
1 region of H2A may have important implications for DNA-binding capabilities of the 
Plasmodium nucleosome.  
 
   
Figure S5: Clustal alignment of Plasmodium spp. canonical histone 2A (H2A). This image shows a 
Clustal alignment of canonical histone 2A (H2A) amino acid sequences from P. berghei ANKA, P. vivax 
isolate Salvador 1 (Sal-1), P. malariae Uganda 01 (UG01) isolate, P. falciparum strain 3D7, P. ovale 
curtisi Ghana 01 isolate (Poc GH01), P. knowlesi macaque-adapted experimental strain H, P. knowlesi 
Malayan strain Pk1A, and mammalian species, M. musculus, R. norvegicus, and H. sapiens sapiens. 
The canonical H2A sequences of P. berghei ANKA, P. vivax Sal-1, P. ovale curtisi, and both P. knowlesi 
strains are 100% identical. P. falciparum and P. malariae share 98% sequence identity with P. berghei 
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ANKA but differ in 3 and 2 amino acids respectively, with two amino acid substitutions each at the 
histone C-terminus. The P. berghei ANKA H2A sequence, and those of the other Plasmodium spp. 
differ considerably from the mammalian sequences, which is easily determined from the Clustal 
alignment above. Most noticeable is the loss of lysine residues at the C-terminal H2A end, with an 
extension of 3 amino acids also. The addition of further lysine residues at the N-terminus, and 
particularly at the Loop 1 region that is heavily involved in DNA interactions, suggests differing 
histone dynamics between Plasmodium parasites and higher order mammals.  
In this image, lysines are indicated by a star (★) above the amino acid letter (K). In Clustal, an 
asterisk (*) below an aligned amino acid indicates that the amino acid is fully conserved. A colon (:) 
underneath an aligned amino acid indicates conservation between residues with strongly similar 
properties (scoring an equivalent of >0.5 the Gonnet PAM 250 matrix (Pearson, 2013)). A full 
stop/period (.) below an aligned amino acid indicates conservation of residues with weakly similar 
properties (roughly equivalent to a score of >0 but <0.5 on the Gonnet PAM 250 matrix (Pearson, 
2013)). No symbol beneath an aligned amino acid signifies that there is no conservation of the amino 
acid or exchange for an amino acid with similar properties.   
 
S1.5 The variant histone 2A (H2A.Z) of P. berghei  
 
In eukaryotes, several histone 2A variants have been described, with some being 
vertebrate-specific, and others, such as H2A.Z and H2A.X, being conserved among 
many eukaryotic lineages (Malik and Henikoff, 2003). The variant H2A.X is conserved 
among many protists, including Giardia, and phosphorylation of this histone variant 
at the C-terminus has been described as a sensitive marker for DNA damage and the 
subsequent repair of a DNA lesion (Redon et al., 2002; Sharma, Singh and Almasan, 
2012). The other highly conserved H2A variant is H2A.Z, which can make up as much 
as ~10% of the H2A complement of an organism, and has been implicated in 
transcriptional activation and nucleosome stability (Redon et al., 2002). In 
Tetrahymena thermophila, substitution of six N-terminal lysines to arginines proved 
lethal to the organism, with studies suggesting that acetylation of N-terminal lysines 
is responsible for modulation of an essential “charge patch” in Tetrahymena H2A.Z, 
with this “charge patch” being instrumental in the formation of histone-DNA and 
histone-protein interactions (Ren and Gorovsky, 2001; Redon et al., 2002).  
 
In Plasmodium spp., only one H2A variant is encoded for in the genome, the highly 
conserved H2A variant, H2A.Z. In the mammals used for comparative analysis in this 
alignment, the H2A.Z amino acid sequences were 100% identical, and all were 128 
 Supplemental Information  
 34 
aa in length (Figure S6; blastp results not shown). In contrast, all but one of the 
Plasmodium spp. H2A.Z sequences were 158 aa in length, with the outlier (P. ovale 
curtisi GH01) most probably diverging as a result of sequence error (Figure S6). The 
protein sequences for P. vivax Sal-1, P. malariae UG01, and both P. knowlesi strains 
were 100% identical. P. berghei ANKA shares 98% sequence identity with these 
human-infective Plasmodium species, differing at only 3 amino acid positions (blastp 
results not shown). With regard to the H2A.Z of P. falciparum 3D7, this parasite 
shares 96% sequence identity with P. berghei ANKA, and 97% sequence identity with 
other human-infective Plasmodium spp. (blastp results not shown). The amino acid 
substitutions between Plasmodium species were confined to position 6 in the N-
terminus and positions 147 to 152 in the C-terminus (Figure S6). 
 
Of course, the most compelling differences when observing an alignment of histone 
H2A.Z amino acid sequences between mammals and Plasmodium spp. are the 
striking extensions of both the H2A.Z N- and C- termini, with largely conserved 
sections of the core H2A.Z protein (Figure S6). At the amino terminus, the 
Plasmodium spp. H2A.Z sequence extends 23 aa upstream of the mammalian 
equivalent, with additional lysine residues at positions 5, 10, 14, 18 and 24 and 
maintaining the conserved H2A.Z K27. At the C-terminus, Plasmodium spp. H2A.Z 
extends 7 aa beyond its mammalian equivalent, with a lysine rich tail (lysines at 
positions 152, 153, 155 and 156) (when counting these lysines, the initial methionine 
of the amino acid sequence was not counted or counted as Met/M 0) (Figure S6). 
The presence of additional N-terminal lysines creates further positions at which 
acetylation of H2A.Z can occur, eliminating a positive charge at the N-terminus and 
allowing active transcription (Ren and Gorovsky, 2001; Redon et al., 2002).  
 
In yeast, the H2A.Z C-terminus, more specifically, the final 20 aa of the H2A.Z C-
terminus, are crucial for incorporation of this histone variant to nucleosomes, and 
the ability of this histone to elicit its function as an antagonist of telomeric silencing 
(Meneghini, Wu and Madhani, 2003; A. Y. Wang et al., 2011). In yeast, H2A.Z variants 
cluster near telomeres and antagonise heterochromatin spread by SIR2 enzymes 
(Meneghini, Wu and Madhani, 2003). Recruitment of H2A.Z during DNA strand break 
repair is also mediated by SUMOylation (incorporation of small ubiquitin-like 
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modifiers) at lysines 125 and 132 of the yeast H2A.Z sequence (Kalocsay, Hiller and 
Jentsch, 2009). In mammals, the K132 residue is lost but the K125 equivalent residue 
is present at position 120 of the H2A.Z amino acid sequence. In Plasmodium spp. the 
equivalent lysine is conserved at position 143 (Figure S6). The addition of a lysine-
rich C-terminal tail to the Plasmodium spp. H2A.Z opens up many possibilities for 
post-translational modifications that could alter chromatin-binding, telomeric de-
silencing, and SUMOylation-based DNA repair mechanisms.   
 
 
 
Figure S6: Clustal alignment of Plasmodium spp. variant 2A (H2A.Z). This image shows a Clustal 
alignment of variant histone 2A (H2A.Z) amino acid sequences from P. berghei ANKA, P. vivax isolate 
Salvador 1 (Sal-1), P. malariae Uganda 01 (UG01) isolate, P. falciparum strain 3D7, P. ovale curtisi 
Ghana 01 isolate (Poc GH01), P. knowlesi macaque-adapted experimental strain H, P. knowlesi 
Malayan strain Pk1A, and mammalian species, M. musculus, R. norvegicus, and H. sapiens sapiens. 
The H2A.Z sequences of P. vivax Sal-1, P. malariae UG01, and both P. knowlesi strains are 100% 
identical. P. falciparum and P. berghei ANKA share 97% and 96% sequence identity with these other 
Plasmodium spp. respectively, but the H2A.Z of P. ovale curtisi GH01 isolate assembly differs 
considerably, most likely owing to issues during genome assembly.  
The Plasmodium H2A.Z sequences differ considerably from those of mammals at their extanded N- 
and C- termini. Ignoring the P. ovale curtisi GH01 assembly, all other Plasmodium spp. H2A.Z 
sequences include an additional 23 aa at their N-termini, and 7 extra amino acids at their C-terminal 
tails, many of these additions being lysine (K) residues that may be subject to post-translational 
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modification. In the above image, lysines are indicated by a star (★) above the amino acid letter (K), 
with all Plasmodium lysines indicated. The final shared lysine between mammalian and Plasmodium 
sequences is located at position 143 (K143), the equivalent of the yeast (S. cerevisiae) K125, which 
is SUMOylated in the event of DNA strand break repair.  
In Clustal, an asterisk (*) below an aligned amino acid indicates that the amino acid is fully conserved. 
A colon (:) underneath an aligned amino acid indicates conservation between residues with strongly 
similar properties (scoring an equivalent of >0.5 the Gonnet PAM 250 matrix (Pearson, 2013)). A full 
stop/period (.) below an aligned amino acid indicates conservation of residues with weakly similar 
properties (roughly equivalent to a score of >0 but <0.5 on the Gonnet PAM 250 matrix (Pearson, 
2013)). No symbol beneath an aligned amino acid signifies that there is no conservation of the amino 
acid or exchange for an amino acid with similar properties. 
 
S1.6 The canonical histone 2B (H2B) of P. berghei  
 
Unlike its dimerising partner (H2A), H2B in eukaryotes has very few variants (Malik 
and Henikoff, 2003). In humans, H2B has 16 isoforms: 13 of which are expressed in 
somatic cells and 3 of which are testis-specific (Molden et al., 2015). In Plasmodium 
spp., two H2B proteins are encoded for: canonical H2B and H2B.Z. In mammals, the 
H. sapiens sapiens H2B sequence shares 94% sequence identity with that of M. 
musculus, and 93% sequence identity with that of R. norvegicus, with all sequences 
being 127 aa in length (blastp results not shown). In comparison, all Plasmodium 
spp. H2B amino acid sequences are either 117 aa or 118 aa in length, all differing 
from the mammalian sequence at their amino termini (Figure S7).  
 
Though the majority of the amino acid sequence of H2B is identical between 
Plasmodium species, only the H2B sequences of both P. knowlesi strains are 100% 
identical. These sequences, along with that of P. falciparum 3D7, are 117 aa in 
length and differ from the other Plasmodium spp. in that the A/T residue at position 
15 has been lost (Figure S7). One notable difference between Plasmodium species 
however is at position 78, a position that contains a lysine in all mammalian H2B 
sequences, but which is swapped for an arginine in four of the seven Plasmodium 
spp. sequences (Figure S7). As in the mammalian H2B sequences, P. berghei ANKA, 
and both P. knowlesi strains maintain a K78 residue. However, in P. falciparum 3D7, 
P. ovale curtisi GH01, P. malariae UG01, and P. vivax Sal-1, this position is occupied 
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by R78. It is unknown whether this amino acid substitution may confer any functional 
differences to the H2B proteins of these particular Plasmodium isolates.  
 
As can be discerned from Figure S7, there are few changes to the C-terminus of 
canonical H2B in Plasmodium spp. and this is most likely due to the presence of a C-
terminal a-helix (aC) in H2B that is essential for its interaction with nucleosomal 
DNA. The final conserved lysine residue between mammals and Plasmodium spp. is 
at position 113 of the Plasmodium H2B sequences, a lysine that is mono-
ubiquitinated at the C-terminal tail of H2B, and is responsible for modifications on 
H3 and H4 proteins (Malik and Henikoff, 2003). Inversely, the N-terminal tails of 
Plasmodium spp. H2B proteins can be distinguished from their mammalian 
equivalents by their loss of 9 amino acids, coupled with the loss of lysines at positions 
6, 21, 24, and 25. These amino acid substitutions have the ability to make 
considerable changes to the overall structure of the H2B protein at its first a-helix 
(a1) (Malik and Henikoff, 2003).  
 
Furthermore, the highly basic amino acid domain from positions 30-37 in the 
mammalian H2B, known as the histone H2B repression (HBR) domain, are not only 
retained in Plasmodium spp. (corresponding to positions 21-28), but are flanked by 
additional lysine residues from positions 18-20, indicating further possible 
mechanisms by which nucleosome assembly can be regulated by post-translational 
means in the malaria parasite (Mao et al., 2016).   
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Figure S7: Clustal alignment of Plasmodium spp. canonical histone 2B (H2B). The image above 
shows a Clustal alignment of canonical histone 2B (H2B) amino acid sequences from P. berghei ANKA, 
P. vivax isolate Salvador 1 (Sal-1), P. malariae Uganda 01 (UG01) isolate, P. falciparum strain 3D7, 
P. ovale curtisi Ghana 01 isolate (Poc GH01), P. knowlesi macaque-adapted experimental strain H, 
P. knowlesi Malayan strain Pk1A, and mammalian species, M. musculus, R. norvegicus, and H. sapiens 
sapiens. The H2B sequences of all Plasmodium spp. differ slightly from one another, with the 
exception of both P. knowlesi strains. When comparing Plasmodium H2B to mammalian H2B, it is 
clear from a Clustal alignment that the amino termini of Plasmodium spp. H2B histones differ 
considerably from those of mammals. Though certain lysine residues are conserved, more have been 
added upstream of the histone H2B repression (HBR) domain (positions 21-28 in Plasmodium spp.) 
suggesting alterations at the secondary and tertiary structural level of H2B in Plasmodium spp. These 
changes may manifest functionally at different stages of the parasite life cycle. In the above image, 
lysines are indicated by a star (★) above the amino acid letter (K), with all Plasmodium lysines 
indicates.     
In Clustal, an asterisk (*) below an aligned amino acid indicates that the amino acid is fully conserved. 
A colon (:) underneath an aligned amino acid indicates conservation between residues with strongly 
similar properties (scoring an equivalent of >0.5 the Gonnet PAM 250 matrix (Pearson, 2013)). A full 
stop/period (.) below an aligned amino acid indicates conservation of residues with weakly similar 
properties (roughly equivalent to a score of >0 but <0.5 on the Gonnet PAM 250 matrix (Pearson, 
2013)). No symbol beneath an aligned amino acid signifies that there is no conservation of the amino 
acid or exchange for an amino acid with similar properties. 
 
S1.7 The variant histone 2B (H2B.Z) of P. berghei  
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In P. berghei, there is only one variant histone H2B, termed H2B.Z, that most closely 
resembles the human H2B variant 1-L (63% sequence identity), the mouse H2B 
variant 1-B (63% sequence identity), and the rat H2B variant 1-B (63% sequence 
identity; blastp results not shown). Unlike the limited amount of information so far 
gleaned about the interactions and functions of other canonical and variant histone 
in Plasmodium spp., the role of H2B.Z has been determined, at least in part, in P. 
falciparum. Using P. falciparum strain 3D7, it was established that H2A.Z/H2B.Z 
double-variant nucleosomes preferentially localise to euchromatic, AT-rich, 
intergenic regions, and demarcate promoters and putative epigenetic regulatory 
regions of the genome (Hoeijmakers et al., 2013). In a second study, and using the 
same parasite, it was also determined that the H2A.Z/H2B.Z double-variant 
nucleosome was enriched at the promoter of the single active var gene, and so was 
implicated in control of monoallelic var gene expression and P. falciparum virulence 
(Petter et al., 2013).  
 
Though the role of H2A.Z/H2B.Z double-variant nucleosomes in the active 
transcription of a single P. falciparum var gene, and in marking promoters in 
euchromatin, are known at present (Hoeijmakers et al., 2013; Petter et al., 2013), 
it remains to be seen whether post-translational modifications of the H2B.Z variant 
histone can also play a role in modulating H2A.Z/H2B.Z-promoter occupancy, and to 
what extent such modifications can influence transitions from one parasite life cycle 
stage to another. Could modification of an H2B.Z residue affect H2A.Z/H2B.Z 
demarcation, and thus transcriptional activation, of an AP2 transcriptional 
regulator, for example?   
 
When comparing the Plasmodium spp. H2B.Z amino acid sequences to those of the 
most similar mammalian H2B variants in human, rat and mouse, it can be seen that, 
once more (as with canonical H2B), the Plasmodium spp. H2B.Z differs most 
significantly at the amino terminus. In Plasmodium H2B.Z sequences, shortening of 
the N-terminal tails may have consequences for the a1 and a2 helices of the histone 
secondary structure (Malik and Henikoff, 2003). The H2B.Z C-terminus in 
Plasmodium spp. again remains the most unaltered portion of the histone variant 
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when compared with its mammalian counterpart, with retention of K116 (the amino 
acid position in Plasmodium spp.), and its flanking tyrosine (Y) and threonine (T) 
residues, possibly maintaining key roles in trans-histone H3-H4 methylation 
(Chandrasekharan et al., 2010). Maintenance of threonine 115 (T115) in Plasmodium 
spp. sequences (homologous to the yeast T122) reinforces the idea that this region 
of H2B.Z is involved in conserved mechanisms of chromatin compaction and that 
modifications at these sites may have important consequences on histone-histone 
and histone-DNA binding (C. Y. Wang et al., 2011).     
 
When examining Plasmodium spp. H2B.Z sequences alone, all H2B.Z histones are 123 
aa in length, with those of P. berghei ANKA, P. vivax Sal-1, P. ovale curtisi GH01, 
and both P. knowlesi strains being 100% identical (Figure S8). Both P. malariae UG01 
and P. falciparum 3D7 H2B.Z sequences differ at only one amino acid each. In 
histone H2B.Z of P. malariae UG01, a serine (S) at position 9 in other Plasmodium 
species is replaced by an alanine (A). In P. falciparum H2B.Z, a glycine (G) at position 
121 (not counting the initial methionine residue) is replaced by an alanine (A). All 
other amino acid positions remain identical.        
 
  
Figure S8: Clustal alignment of Plasmodium spp. variant histone 2B (H2B.Z). The image above 
shows a Clustal alignment of variant histone 2B (H2B.Z) amino acid sequences from P. berghei ANKA, 
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P. vivax isolate Salvador 1 (Sal-1), P. malariae Uganda 01 (UG01) isolate, P. falciparum strain 3D7, 
P. ovale curtisi Ghana 01 isolate (Poc GH01), P. knowlesi macaque-adapted experimental strain H, 
P. knowlesi Malayan strain Pk1A, and mammalian species, M. musculus, R. norvegicus, and H. sapiens 
sapiens. The H2B.Z amino acid sequences of Plasmodium spp. are remarkably similar. The H2B.Z 
sequences of P. berghei ANKA, P. ovale curtisi GH01, P. vivax Sal-1, and both P. knowlesi strains, are 
100% identical. P. falciparum 3D7, and P. malariae UG01 H2B.Z sequences each differ at only one 
amino acid position each (mutations G121A and S9A respectively). Between Plasmodium spp. and the 
closest mammalian H2B variants, the C-termini of all sequences remain similar, but with alterations 
to the N-termini that may manifest in the secondary a1 and a2 helices structures of the H2B.Z 
protein. In the above image, all Plasmodium spp. lysines are indicated by a star (★). 
In Clustal, an asterisk (*) below an aligned amino acid indicates that the amino acid is fully conserved. 
A colon (:) underneath an aligned amino acid indicates conservation between residues with strongly 
similar properties (scoring an equivalent of >0.5 the Gonnet PAM 250 matrix (Pearson, 2013)). A full 
stop/period (.) below an aligned amino acid indicates conservation of residues with weakly similar 
properties (roughly equivalent to a score of >0 but <0.5 on the Gonnet PAM 250 matrix (Pearson, 
2013)). No symbol beneath an aligned amino acid signifies that there is no conservation of the amino 
acid or exchange for an amino acid with similar properties. 
 
S1.8 The histone H3-like centromeric protein CSE4 (CenH3) of P. berghei  
 
In eukaryotes, centromere-specific H3 variants (CenH3s) are specialised H3 variants 
for chromatin packaging during mitosis and are atypical, rapidly evolving H3 variant 
histones (Malik and Henikoff, 2003). In P. falciparum 3D7, the CenH3 variant histone 
occupies a 4-4.5 kb region of each of the 14 chromosomes and localises to a single 
nuclear location prior to mitosis and cytokinesis (Hoeijmakers et al., 2012). Using P. 
falciparum strain FCK2 (a local strain to Karnataka, India), the ability of the PfCenH3 
to complement the loss of its homologue in yeast (Cse4p) demonstrated its ability 
to mark active centromeres for kinetochore assembly, and therefore to facilitate 
chromosome segregation (Verma and Surolia, 2013).  
 
A comparison of the amino acid sequences of the CenH3 histones of human, rat, and 
mouse, and between Plasmodium species, highlights the rapid evolution of this H3 
variant (Figure S9). Between Plasmodium species alone, only the P. knowlesi strains 
share an identical CenH3 protein, with this sequence sharing 87% sequence identity 
with P. vivax Sal-1, 74% sequence identity with both P. malariae UG01 and P. 
falciparum 3D7, 73% sequence identity with P. ovale curtisi GH01, and 68% sequence 
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identity with P. berghei ANKA (blastp results not shown). Among all CenH3 histones, 
including those of mammals, it is the essential C-terminal end that shows the highest 
conservation (Figure S9). In the P. falciparum/S. cerevisiae complementation study 
(Verma and Surolia, 2013), the carboxy terminal histone fold domain (HFD) that 
harbours a CENP-A targeting domain (CATD) (termed CENP-C in P. falciparum), was 
indispensable for centromeric-targeting and CenH3 function.  
 
Between all mammal and Plasmodium species shown in Figure S9, it is the N-termini 
that have evolved most rapidly, in line with other eukaryotic lineages (Malik and 
Henikoff, 2003). In Plasmodium CenH3 sequences, a lysine pair (K4 and K5) is 
conserved among all species at the N-terminus, a site that is perhaps targetable for 
post-translational modification, though no such modifications have been identified 
to date (Trelle et al., 2009; Coetzee et al., 2017).  
 
 
 
Figure S9: Clustal alignment of Plasmodium spp. variant histone H3-like CSE4 proteins and 
mammalian centromere-specific histone 3 (CenH3). This image shows a Clustal alignment of the 
variant centromere-specific H3 histones (CenH3s) of M. musculus, R. norvegicus, and H. sapiens 
sapiens, in comparison with the equivalent histone H3-like CSE4 protein sequences of P. berghei 
ANKA, P. vivax isolate Salvador 1 (Sal-1), P. malariae Uganda 01 (UG01) isolate, P. falciparum strain 
3D7, P. ovale curtisi Ghana 01 isolate (Poc GH01), P. knowlesi macaque-adapted experimental strain 
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H, and P. knowlesi Malayan strain Pk1A. In all aligned sequences, the C-termini of CenH3 proteins 
show quite significant conservation, likely owing to the essentiality of the C-terminus of CenH3 for 
centromeric-targeting and correct chromosome segregation during mitosis. As the sequence reaches 
the amino terminus, the CenH3 protein shows signs of evolution, even between Plasmodium spp. 
Though an initial K4/K5 pair is conserved among Plasmodium sequences, CenH3 sequences differ 
considerably, often with deletions of a series of amino acids. In this image, all Plasmodium spp. 
lysines are indicated by a star (★) above the sequence.   
In Clustal, an asterisk (*) below an aligned amino acid indicates that the amino acid is fully conserved. 
A colon (:) underneath an aligned amino acid indicates conservation between residues with strongly 
similar properties (scoring an equivalent of >0.5 the Gonnet PAM 250 matrix (Pearson, 2013)). A full 
stop/period (.) below an aligned amino acid indicates conservation of residues with weakly similar 
properties (roughly equivalent to a score of >0 but <0.5 on the Gonnet PAM 250 matrix (Pearson, 
2013)). No symbol beneath an aligned amino acid signifies that there is no conservation of the amino 
acid or exchange for an amino acid with similar properties. 
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